Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning.
Market Analysis and Insights: Global Antiemetics Market
The global Antiemetics market is valued at US$ 3816.8 million in 2019. The market size will reach US$ 4931.5 million by the end of 2026, growing at a CAGR of 3.7% during 2021-2026.
Global Antiemetics Scope and Market Size
Antiemetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiemetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Segment by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics
Dizziness
Pregnancy
Food poisoning
Emotional stress
By Company
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Market Analysis and Insights: Global Antiemetics Market
The global Antiemetics market is valued at US$ 3816.8 million in 2019. The market size will reach US$ 4931.5 million by the end of 2026, growing at a CAGR of 3.7% during 2021-2026.
Global Antiemetics Scope and Market Size
Antiemetics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiemetics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist
Antihistamines (H1 histamine receptor antagonists)
Cannabinoids
Benzodiazepines
Anticholinergics
Steroids
Others
Segment by Application
Chemotherapy
Motion sickness
Gastroenteritis
General anesthetics
Opioid analgesics
Dizziness
Pregnancy
Food poisoning
Emotional stress
By Company
GlaxoSmithKline
Merck
Sanofi Aventis
Bristol Myers Squibb
Eli Lilly
Pfizer
Astellas
Johnson & Johnson
Baxter
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.